All In Biotech

Free tool

FAERS Monitor: Levetiracetam In Sodium Chloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202543 or its brand name (Levetiracetam In Sodium Chloride, Levetiracetam). Reports on generic versions are filed under their own applications.

Reports

78,636

Serious

69,598

89% of reports

Hospitalization

28,879

Death reported

7,204

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective9,213
  • seizure8,983
  • off label use6,638
  • maternal exposure during pregnancy3,194
  • epilepsy2,826
  • foetal exposure during pregnancy2,642
  • drug interaction2,532
  • fatigue2,500
  • condition aggravated2,341
  • somnolence2,130
  • status epilepticus2,102
  • generalised tonic-clonic seizure2,051
  • toxicity to various agents1,890
  • fall1,864
  • dizziness1,783

Reports by year received

View as table
YearReports
200487
2005118
200693
2007161
2008212
2009665
2010685
2011994
20121,435
20131,616
20141,555
20152,386
20163,296
20174,570
20187,115
20197,970
20206,820
20216,805
20226,133
20236,861
20247,538
20256,507
20265,011

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,975,523 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
status epilepticusSignal2,10260.958.2100,891
generalised tonic-clonic seizureSignal2,05137.736.064,210
epilepsySignal2,82627.126.164,642
seizureSignal8,98322.522.0170,879
maternal exposure during pregnancySignal3,1949.99.624,750
foetal exposure during pregnancySignal2,6429.08.618,118
drug interactionSignal2,5324.34.26,407
toxicity to various agentsSignal1,8903.02.92,544
somnolenceSignal2,1302.82.72,551
condition aggravatedSignal2,3412.12.01,298
off label useSignal6,6382.02.03,620
drug ineffective9,2131.91.83,991
fall1,8641.51.4314
dizziness1,7831.00.94
fatigue2,5000.90.860

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.